We are live on ! Find out more
ISPC icon

iSpecimen

11 hedge funds and large institutions have $103K invested in iSpecimen in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

49% more capital invested

Capital invested by funds: $69.1K → $103K (+$34K)

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

10% more funds holding

Funds holding: 1011 (+1)

0% less ownership

Funds ownership: 0%0% (-0%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

ISPC Hedge Fund Activity: Q2 2024 in Review

11 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q2 2024, worth a combined $103K — up 49% from $69.1K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ISPC positions and 4 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $13.7K. The largest seller was Vanguard Group, cutting an estimated $12.2K.

  • 11 institutional investors held iSpecimen (ISPC) as of Q2 2024, up from 10 in Q1 2024.
  • Funds reported $103K of iSpecimen stock for Q2 2024, up 49% quarter-over-quarter.
  • 5 funds opened new iSpecimen positions in Q2 2024 and 4 closed out, a net change of +1 holder.
  • The largest iSpecimen buyer in Q2 2024 was HRT Financial, an estimated $13.7K added.
  • The largest iSpecimen seller in Q2 2024 was Vanguard Group, an estimated $12.2K sold.

Based on aggregated 13F filings for Q2 2024.